Robert Lustig: The Hidden Fat That Matters—Visceral Fat, Waist Size, and Key Biomarkers #fat #obese
Speaker emphasizes that subcutaneous fat visible externally can be benign, while hidden fat (visceral and liver fat) is the critical risk factor for chronic disease. The speaker states that about 60% of normal-weight people have visceral or liver fat and recommends waist circumference as a cheap, sensitive (but not specific) biomarker for detecting increased visceral/liver fat.
Questions this video answers
60%.
Waist circumference.
Chapters
More from Dr.
Hippocrates said, let thy food be thy medicine #obesity #metabolicsyndrome #lustig #shorts #health
Bill Wilson, MD: Why GLP-1 Drugs Are Overpriced—and How Compounding and Competition Could Fix It
Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.
The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig
Bill Wilson, MD: GLPs May Reverse Carb Syndrome—Helping Patients Reach Zero and Sustain with Diet
Why Everything You Knew About Obesity Is Wrong | Dr. Robert Lustig on Sugar & Metabolic Syndrome
Robert Lustig, MD: How Fructose Fuels Fatty Liver, Oxidative Stress, and Metabolic Disease #fructose
Robert Lustig, MD: The 3 Types of Fat Fueling Insulin Resistance and Disease #insulin resistance
Bill Wilson, MD: GLPs May Reverse CARB Syndrome. Helping Patients Reach Zero and Sustain with Diet